by Market Overview:
A Beating heart patch is a bioengineered patch that supports the native heart tissue and restores its functions during a heart attack. Beating heart patches are more advantageous than conventional methods as they provide living tissue that integrates and contracts synchronously with the host heart tissue.
Market key trends:
One of the key trends in the beating heart patch market is the increasing research activities to develop advanced patches made from biomaterials and living cells. For instance, researchers are developing bioengineered patches made from materials that support cellular ingrowth and vascularization post-implantation. Some of the biomaterials being researched are extracellular matrix proteins, hydrogels, and nanofibers. These next-generation patches made of biomaterials and cells aim to restore the structural, mechanical, and electrochemical properties of the injured heart tissue. The advanced patches also mimic native extracellular matrix for cellular communication and tissue remodeling. Such ongoing research and development of novel patches are expected to drive the beating heart patch market during the forecast period.
The global Beating Heart Patch Market Demand is estimated to be valued at US$ 223.6 Mn in 2023 and is expected to exhibit a CAGR of 7.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
The beating heart patch market has been witnessing rising adoption of decellularized extracellular matrix biomaterials for tissue engineering. These biomaterials provide a scaffold for host cells to repopulate and revascularize. They mimic the native tissue properties and help in efficient repair and regeneration of damaged cardiac tissues. Researchers are focusing on modifying decellularization techniques to maximize removal of cellular components while preserving the architecture and biological activity of extracellular matrix.
SWOT Analysis
Strength: Biomimetic property of ECM scaffolds promote cell infiltration and tissue development. They elicit a mild host response without triggering an immune reaction.
Weakness: Difficulty in obtaining adequate amounts of ECM for large animal and human trials. Decellularization processes can impact ECM structure.
Opportunity: Growing VALVE disease burden worldwide increases need for novel cardiac repair therapies. ECM biomaterials present opportunities for developing ‘off-the-shelf’ heart patches.
Threats: High costs associated with development and regulatory approval of new biomaterials. Safety issues need to be addressed for clinical translation.
Key Takeaways
The global beating heart patch market is expected to witness high growth, exhibiting CAGR of 7.6% over the forecast period, due to increasing prevalence of CVD and rising VALVE disease burden worldwide.
The North American region currently dominates the beating heart patch market due to presence of major market players and higher adoption of advanced tissue-engineered therapies. However, Asia Pacific region is expected to emerge as the fastest growing market over the coming years owing to increasing healthcare investments, rising medical tourism, and growing research focus on cardiac regenerative therapies.
Key players operating in the beating heart patch market are Harvard Apparatus Regenerative Technology, Inc.,CorMatrix Cardiovascular, Inc.,Acell Inc.,Cytograft Tissue Engineering, Inc.,Biomatrica, Inc.,Tepha, Inc.,LifeNet Health, Inc.,CollPlant Ltd.,SynCardia Systems, LLC,Cardiovascular Systems, Inc.,Biotronik SE & Co. KG,Admedus Ltd.,C. R. Bard, Inc.,W. L. Gore & Associates, Inc., Xenogenics Corporation. These companies are focused on advancing decellularization technologies and developing novel biomaterial scaffolds for improved cardiac repair.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
